Answers are grounded in this paper and cite their sources.
Evaluates survival outcomes in patients with brain metastases from prostate cancer, suggesting treatment implications.
Background: Brain metastases (BrM) from prostate cancer (PC) are rare. This study sought to evaluate their prevalence, clinical features, treatment modalities, and survival outcomes. Methods: From a database of BrM patients, we analyzed 28 cases of prostate cancer treated at our center between 2008 and 2023. OS did not significantly differ between patients with a single versus multiple BrM or patients with castrate-sensitive versus castrate-resistant PC. Conclusion: BrMs from prostate cancer are rare and predominantly occur in patients with advanced, castrate-resistant disease, often accompanied by other metastases. This analysis enhances our understanding of the disease trajectory and informs treatment discussions.
No takes yet. Share an insight, caveat, or question.
Jamora et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: